Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Hcv-Genotype'
Hcv-Genotype published presentations and documents on DocSlides.
Abbott RealTime HCV Genotype II PMA CONFIDENTIAL
by desha
mHCV Genotype II Key to symbols used Global Tra...
Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6
by pasty-toler
ASTRAL-1. Phase 3. . Treatment. . Naïve & ...
% of Global HCV Seropositive Cases
by faith
Global epidemiology of hepatitis C virus infection...
HCV Assays: Impact on HCV Studies
by blanko
& . Update on HCV . blood bank protocol. . Ov...
HCV cure by IFN-free DAAs is associated with increased survival in patients with HCV-related HCC
by jovita
Hansen Dang,. 1,2*. Yee Hui Yeo,. 1*. Satoshi Ya...
Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1
by danika-pritchard
NIAID Retreatment. Phase . 2a . Treatment. . Exp...
Elbasvir-Grazoprevir in Treatment-Naïve HCV Genotype 1, 4 or 6
by celsa-spraggs
C-EDGE Treatment Naïve (TN). Phase 3. . Treatme...
Sofosbuvir + Ribavirin in HCV Genotype 1
by pamella-moone
NIH SPARE. Phase . 2. Treatment. . Naïve . (unf...
Future HCV Treatment Paradigms
by kittie-lecroy
Mark Sulkowski, MD . Professor of Medicine. Medic...
FISSION Design Objective
by travis
Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...
Boceprevir with PEG + RBV in Genotype 1
by caroline
SPRINT. -1. Phase . 2. Treatment. . Naïve. Kwo. ...
Ghazala Rubi B.Sc , M.Sc
by badra
,. F.I.B.M.S;. MPhil. (. Mol.Bio. ). PhD (Human G...
This product is intended to be used to guide the selection of treatmen
by rosemary
siemens.com/molecular Optimize Treatment Decisions...
OBV/PTV/r DSV RBV OBV/PTV/r
by ellena-manuel
DSV . placebo. Randomisation*. Partial blind. 1...
Sofosbuvir-Velpatasvir in Genotype 2
by stefany-barnette
ASTRAL-2*. Phase 3. . Treatment. . Naïve &...
Telaprevir
by karlyn-bohler
BID versus q8 in Treatment Naïve GT-1. OPTIMIZE ...
LDV/SOF 90/400 mg
by aaron
qd. Non-randomised. Open-label. N =. 21. W12. SV...
OBV/PTV/r
by conchita-marotz
OBV/PTV/r + RBV. Randomisation*. 1 : 1. Open labe...
SAPPHIRE-I
by ellena-manuel
Feld JJ. NEJM . 2014;370:1594-1603. SAPPHIRE-I . ...
Are Pan-Genotypic Therapies Ready for Prime Time?
by lois-ondreau
3. Rd. International . HIV/Hepatitis . Coinfecti...
Hepatitis C Drug Pipeline
by cheryl-pisano
HCV WORLD CAB . FEBRUARY 2014. BANGKOK, THAI...
≥ 18 years HCV genotype 1, 2, 4, 5, 6
by alexa-scheidler
HCV RNA ≥ 1000 IU/mL. Treatment-naïve or treat...
HAS THERE EVER BEEN A NATIONAL ESTIMATE OF HCV PREVALENCE IN THE GENERAL POPULATION FROM A ROBUST*
by jesse588
Mandatory criteria: . Probability based sampling. ...
MM: HCV and Cirrhosis Patient Case
by devin732
Chris Kolkman. PrimaryOne. Health. Meet MM. Patie...
Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis
by ahmir
ASTRAL-4. Source: Curry MP, et al. N Engl J Med. 2...
HIV & HCV through the Medicine Wheel
by winnie
Our Services. Emotional:. Reactions. Feelings abou...
NITCAR HCV Audit Chloe Eaton, Suzie English, Ben Warne
by candy
Supervising Consultant: Dr K. . Rolfe. Update: Mar...
Darla Peterson, BS, HIV/HCV Program Manager
by catherine
Teri Griep-Langholz, RN, HIV/HCV Program Nurse Cas...
The Role of Diagnostics in the Management of HCV and HIV
by zoe
Presented by: Thomas E. Burgess, PhD, DABCC, FAACC...
Sofosbuvir + Ribavirin in HCV Recurrence
by williams
Following Liver Transplantation. Phase 2. Charlton...
EASL 2019 HCV Conference Update
by sophia
April 10. –14. , 2019. Vienna, Austria. Disclaim...
Hepatitis C Virus HCV
by danya
Infects 30,000 people in the U.S. each year. Over...
Hepatitis C Virus HCV Infection Testing for Diagnosis31
by joanne
Conrmed Unconrmed Unconrmed ...
Revised 122012 HEPATITIS C VIRUS HCV Hepatitis means inflammation
by madeline
Revised 12/2012 What are the symptoms of HCV infec...
Aptima HCV RNA Qualitative Assay
by delilah
Aptima HCV RNA Qualitative Assay1 500237 Rev. 003 ...
Challenge and Opportunity for HCV Elimination among Young PWID in New York City: Relatively Low RNA
by WannabeRockstar
seroconversion. and genetically linked HCV infect...
Align OPTN Policies with the 2013 PHS Guideline for Reducing Transmission of HIV, HBV, and HCV Thro
by SoulfulDreamer
(Resolution 13). Ad Hoc Disease Transmission Advis...
Economic Impact of Eliminating HCV
by InLoveWithLife
H. . Razavi. April 13, 2016. HCV Economic impact m...
HIV-HCV Coinfection in the era of effective antiviral therapy
by mia
Mark Sulkowski, . MD. Professor of Medicine. Medic...
Treatment of Chronic HCV
by lam
with Direct-Acting Antivirals (DAAs). www.hcvguide...
Load More...